Sign up to save your podcasts
Or
Share The First Longevity Pharma — How Lilly Became the Machine for Immortality
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The First Longevity Pharma — How Lilly Became the Machine for Immortality
Eli Lilly just entered the longevity race with retatrutide - a triple-receptor drug showing 28% weight loss and cellular aging reversal. We break down how 13 billion dollars in GLP-1 revenue is funding the future of anti-aging medicine, AI drug discovery, and why Big Pharma's institutional validation marks the professionalization of longevity science. This is the moment pharmaceutical scale meets lifespan extension. #GLP1 #Longevity #Retatrutide #EliLilly #AntiAging #Biotech #DrugDiscovery #HealthSpan
Watch on YouTube: https://www.youtube.com/watch?v=qaN42HaEWzw
View all episodes
By Jim HallEli Lilly just entered the longevity race with retatrutide - a triple-receptor drug showing 28% weight loss and cellular aging reversal. We break down how 13 billion dollars in GLP-1 revenue is funding the future of anti-aging medicine, AI drug discovery, and why Big Pharma's institutional validation marks the professionalization of longevity science. This is the moment pharmaceutical scale meets lifespan extension. #GLP1 #Longevity #Retatrutide #EliLilly #AntiAging #Biotech #DrugDiscovery #HealthSpan
Watch on YouTube: https://www.youtube.com/watch?v=qaN42HaEWzw